The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
5 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,497,173 in first-year total cost, median $294,474.
Most frequent study sections
- Special Emphasis Panel[ZDA1 CEM-S (M1)]5
Most frequent institutions
- BOULDER CARE, INC.1
- LABSYS, LLC1
- SANO HEALTHCARE CONSULTANTS, LLC1
- TENVOS INC.1
- VITAN-BIOTECH, LLC1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2024 | Advancing Access to Opiate Care and Treatment through a Novel Liquid Methadone Dispensing Device and SMART Container1R43DA061387-01 | KENDRICK, EDWIN | SANO HEALTHCARE CONSULTANTS, LLC, CA | $319,000 | ZDA1 |
| 2024 | Right Tools, Right Time, Right Place: Telehealth for Opioid Use Disorder in Vulnerable Settings1R44DA061386-01 | PAPES, STEPHANIE | BOULDER CARE, INC., OR | $297,061 | ZDA1 |
| 2024 | Wearable Continuous Drug Monitoring Device for Personal Medications in Opioid Use Disorders (CDM-MOUD)1R43DA061397-01 | HUANG, YUEWANG, ZHE | LABSYS, LLC, MI | $294,474 | ZDA1 |
| 2024 | Field-Deployable, low-Cost Point-of-Need urine test strips for mobile quantification of SUD medication drugs and their metabolites1R43DA061396-01 | ZHOU, XICHUN | VITAN-BIOTECH, LLC, CO | $293,468 | ZDA1 |
| 2024 | Remote and Non-Invasive Opioid Use Screening to Lower Barriers to Substance Use Disorder Diagnosis and Treatment1R43DA061400-01 | SEIILOVA-OLSON, RIMA | TENVOS INC., CA | $293,170 | ZDA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.